Smith Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 26-05-2024
- Paid Up Capital ₹ 0.17 M
as on 26-05-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.56 M
as on 26-05-2024
About Smith Life Sciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹6.56 M.
Kaushik Patel and Deep Patel serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC052990
- Company No.
052990
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Smith Life Sciences Private Limited offer?
Smith Life Sciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Diclofenac, Aceclofenac.
Who are the key members and board of directors at Smith Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Patel  | Director | 20-Dec-2010 | Current |
| Deep Patel | Director | 20-Feb-2008 | Current |
Financial Performance of Smith Life Sciences.
Smith Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Smith Life Sciences?
In 2017, Smith Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dhanshree Housing Private LimitedActive 20 years 8 monthsKaushik Patel and Deep Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Ahmedabad Merchantile Co-Operative Bank Limited Creation Date: 30 Nov 2013 | ₹0.96 M | Open |
Union Bank Of India Creation Date: 01 Feb 2013 | ₹2.80 M | Open |
Union Bank Of India Creation Date: 11 Jan 2013 | ₹2.80 M | Open |
How Many Employees Work at Smith Life Sciences?
Unlock and access historical data on people associated with Smith Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smith Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smith Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
